Medical News

RSS

AlphaCore Pharma commences ACP-501 Phase 1 study in coronary arterial disease

AlphaCore Pharma, a biopharmaceutical company developing ACP-501 (rhLCAT) for the treatment of high risk atherosclerosis and serious lipid metabolism disorders, today announced the initiation of a Phase 1 study of ACP-501 in patients with stable coronary arterial disease.

31 Mar 2012

HIT raises $2.75 M USD in Series A funding

HIT Application Solutions, a leading healthcare technology development company, announced today the company has raised $2.75 M USD in its Series A funding effort.

31 Mar 2012

Cancer patients with CDI may benefit from DIFICLIR drug

New data presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrate that in cancer patients with CDI, DIFICLIR(fidaxomicin) may offer significant benefits in terms of clinical cure, recurrence and sustained clinical cure.

31 Mar 2012

Intronix launches Myoguide Needle EMG Guided Injection System

Great things come in small packages, or at least that's what leading neurologists, physiatrists and clinicians are now discovering with the revolutionary Myoguide Needle EMG Guided Injection System. The breakthrough technology, which has just received 510(k) clearance from the United States Food and Drug Administration, gives practitioners a superior way to deliver targeted injections for musculoskeletal pain, spasticity, fibromyalgia, and even cosmetics.

31 Mar 2012

CIC total revenue for fiscal 2011 increases 82% to $1,546,000

Communication Intelligence Corporation, a leading supplier of electronic signature solutions and the recognized leader in biometric signature verification, today reported total revenue of $1,546,000 for the year ended December 31, 2011, an increase of $695,000 or 82%, compared to total revenue of $851,000 in the prior year.

31 Mar 2012

Cardium launches Excellagen wound care product

Cardium Therapeutics today announced market introduction of its Excellagen professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers and other dermal wounds.

31 Mar 2012

SAP protein promotes deposition of amyloid beta in Alzheimer's

The deposition of amyloid beta in the brain of individuals with Alzheimer's disease is the focus of much research into both its cause and treatment.

31 Mar 2012

Political cartoon: 'In Your Wallet?'

Kaiser Health News provides a fresh take on health policy developments with "In Your Wallet?" By R.J. Matson.

31 Mar 2012

Nmnat enzyme plays a critical role in nerve injury

A new animal model of nerve injury has brought to light a critical role of an enzyme called Nmnat in nerve fiber maintenance and neuroprotection.

31 Mar 2012

ChemoCentryx fourth quarter revenues increase to $26.1 million

ChemoCentryx, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2011.

31 Mar 2012

Diagnostic inflation of ADHD

What experts and the public have already long suspected is now supported by representative data collected by researchers at Ruhr-Universit-t Bochum (RUB) and University of Basel: ADHD, attention deficit hyperactivity disorder, is over-diagnosed.

31 Mar 2012

IPS reports on research study examining knowledge, beliefs of cervical cancer among Argentinian women

Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."

31 Mar 2012

Unapproved, misbranded drug products seized in Missouri

Dara Corrigan, associate commissioner for regulatory affairs for the U.S. Food and Drug Administration, and David M. Ketchmark, Acting U.S. Attorney for the Western District of Missouri, announced today that U.S. Marshals have seized drugs being held by Notions-n-Things Distribution of Bogard, Mo. Yesterday's seizure follows a civil forfeiture complaint that was filed in the U.S. District Court in Kansas City, Mo.

30 Mar 2012

Blood levels of PCBs in polar bear cubs appear to have dropped

It's never been easy to be a polar bear. They may have to go months without eating. Their preferred food, seal, requires enormous luck and patience to catch. Add to that the melting of Arctic sea ice due to climate change, and the poisoning of the Arctic by toxic chemicals, and it's easy to see why polar bears worldwide are in trouble.

30 Mar 2012

Risk of botulism at California fish processing company

The U.S. Food and Drug Administration, in a complaint filed by the Department of Justice, is seeking to stop the processing and distribution of fish products at a California company because of a risk of botulism and other food hazards.

30 Mar 2012

Staggering economic costs of autism will continue to rise

Autism Speaks, the world's leading autism science and advocacy organization, today announced preliminary results of new research that estimates autism costs society a staggering $126 billion per year (U.S.) - a number that has more than tripled since 2006, and annually in the U.K. has reached more than -34 billion (equivalent to $54 billion U.S.).

30 Mar 2012

CINJ experts available for discussion on cancer

April marks National Cancer Control Month, which focuses on the importance of prevention, treatment and research in the fight against cancer.

30 Mar 2012

USAID NTD Program funding cut by nearly 25% in proposed FY13 budget

"The United States Government has played a major role in ensuring that patients with certain [neglected tropical diseases (NTDs)] receive urgently needed treatments through the [USAID] NTD Program, while simultaneously being the largest funder of basic research for NTDs through the National Institutes of Health,"

30 Mar 2012

BPA shows tangible effects on health endpoints at high dosage levels

Endocrine-disrupting chemicals (EDCs)-such as BPA-can show tangible effects on health endpoints at high dosage levels, yet those effects do not predict how EDCs will affect the endocrine system at low doses, according to a recent study accepted for publication in The Endocrine Society's Endocrine Reviews.

30 Mar 2012

Physicians advised to use caution in prescribing sedatives for patients taking opioids

Adverse events associated with taking opioid pain medications increase in patients who concurrently use sedatives and alcohol. A study in The Journal of Pain, published by the American Pain Society, advises physicians to use caution in prescribing sedatives for patients taking opioids, even if there is no history of substance abuse.

30 Mar 2012